European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 3.660
0.00 (0.00%)
Oct 26, 2026, 9:00 AM CET
EBR:ALEMS Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 51.36 | 52.8 | 47.91 | 42.53 | 37.06 | 38.02 |
Revenue Growth | -2.73% | 10.21% | 12.67% | 14.76% | -2.53% | 10491.90% |
Gross Profit Gross Profit Growth | 18.93 | 19.02 | 17.45 | 15.09 | 13.78 | 13.8 |
Operating Income Operating Income Growth | 2.86 | 2.5 | 1.26 | -0.14 | -1.77 | 0.12 |
Net Income Net Income Growth | 1.94 | 1.84 | 0.55 | -0.71 | -5.58 | -0.24 |
Earnings Per Share EPS Growth | 0.46 | 0.43 | 0.13 | -0.18 | -1.32 | -3.52 |
EPS Growth | 5.16% | 237.00% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Africa Africa Growth | 1.87 | 1.52 | 2.64 | 1.59 | 1.25 | 1.26 |
North and South America North and South America Growth | 8.5 | 8.48 | 7.99 | 7.45 | 3.75 | 2.39 |
Asia Asia Growth | 3.67 | 3.77 | 4.79 | 2.86 | 4.19 | 2.12 |
Europe Europe Growth | 22 | 24.75 | 26.13 | 24.88 | 23.88 | 21.25 |
Middle East Middle East Growth | 2.75 | 3.76 | 1.93 | 1.84 | 0.9 | 1.26 |
Oceania Oceania Growth | 0.78 | 0.52 | 0.58 | 0.46 | 0.36 | 0.41 |
Other Countries Other Countries Growth | - | 7.13 | 1.07 | - | - | - |
Total Total Growth | 48.5 | 49.92 | 45.13 | 40.56 | 35.27 | 36.27 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3.08 | 4.89 | 4.58 | 4.2 | 4.23 | 2.43 |
Total Debt Total Debt Growth | 19.25 | 18.68 | 19.85 | 18.77 | 14.79 | 13.5 |
Net Cash (Debt) Net Cash Growth | -16.18 | -13.79 | -15.27 | -14.57 | -10.56 | -11.07 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.82 | -3.26 | -3.61 | -3.44 | -2.49 | -161.75 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 3.95 | 5.38 | 2.56 | -2.27 | 2.09 | 0.35 |
Capital Expenditures CapEx Growth | -2.77 | -2.88 | -3.57 | -2.57 | -2.21 | -1.92 |
Free Cash Flow Free Cash Flow Growth | 1.18 | 2.49 | -1.02 | -4.84 | -0.12 | -1.57 |
Free Cash Flow Growth | -52.89% | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 36.86% | 36.02% | 36.41% | 35.48% | 37.18% | 36.31% |
Operating Margin | 5.58% | 4.74% | 2.62% | -0.32% | -4.79% | 0.31% |
Pretax Margin | 4.27% | 3.61% | 1.57% | -1.67% | -15.07% | -0.64% |
Profit Margin | 3.77% | 3.48% | 1.14% | -1.67% | -15.05% | -0.63% |
FCF Margin | 2.29% | 4.72% | -2.12% | -11.39% | -0.32% | -4.14% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.00 | 11.96 | 46.50 | - | - | - |
P/FCF Ratio | 13.18 | 8.82 | - | - | - | - |
PS Ratio | 0.30 | 0.42 | 0.53 | 0.82 | 2.24 | 0.13 |